Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.276 USD | -1.00% | -1.83% | +106.90% |
Mar. 15 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 04 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
Financials (USD)
Sales 2022 | 4.01 | Sales 2023 | - | Capitalization | 122M |
---|---|---|---|---|---|
Net income 2022 | -32M | Net income 2023 | -24M | EV / Sales 2022 | -27,590,059 x |
Net cash position 2022 | 217M | Net cash position 2023 | 200M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.25
x | P/E ratio 2023 |
-4.94
x | Employees | 82 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.86% |
1 day | -2.68% | ||
1 week | -2.56% | ||
Current month | +9.00% | ||
1 month | +2.20% | ||
3 months | +29.61% | ||
6 months | +133.52% | ||
Current year | +109.00% |
Managers | Title | Age | Since |
---|---|---|---|
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Angela Hu
DFI | Director of Finance/CFO | 40 | 14-12-31 |
Mark Ziats
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald MacAdam
BRD | Director/Board Member | 76 | 18-03-19 |
William McKenzie
BRD | Director/Board Member | 76 | 09-01-31 |
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 8.276 | -1.00% | 17 939 |
24-05-23 | 8.36 | -2.68% | 52,682 |
24-05-22 | 8.59 | -1.72% | 55,781 |
24-05-21 | 8.74 | +2.34% | 51,793 |
24-05-20 | 8.54 | +1.30% | 29,304 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+109.00% | 255M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-2.91% | 21.58B | |
-10.90% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- XBIT Stock